Physician profile
John Dimaio
NPI 1124082904
$9,533.04
in general payments reported to CMS, 2019-2025
21 companies · $1,647 in 2025
The $1,647 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $597 · 2021: $406 · 2022: $1,402 · 2023: $2,683 · 2024: $2,337 · 2025: $1,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,667.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,215.58 | 2019-2025 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $988.03 | 2021-2024 | Avalus, Arctic Front Advance |
| W. L. Gore & Associates, INC. | $906.17 | 2020-2024 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis |
| Artivion, INC. | $510.07 | 2021-2023 | Cryovalve Sg Pulmonary Human Heart Valve, Cardiac Non-Synergraft |
| Atricure, INC. | $281.30 | 2019-2022 | |
| Vascular Graft Solutions INC | $169.01 | 2019 | |
| Abbott Laboratories | $167.08 | 2020-2023 | Ensite |
| Abiomed | $156.24 | 2025 | |
| Bolton Medical INC | $147.92 | 2023 | Treo Abdominal Stent-Graft System |
| Hemosonics LLC | $129.50 | 2022 | |
| Getinge USA Sales, LLC | $121.15 | 2022 | |
| Cook Medical LLC | $119.91 | 2021 | |
| Heartflow, INC. | $110.37 | 2019 | |
| Chiesi USA, INC. | $100.77 | 2023 | |
| Boston Scientific Corporation | $87.48 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $84.82 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $81.19 | 2022 | |
| Genentech USA, INC. | $80.06 | 2024 | Alecensa |
| Intuitive Surgical, INC. | $60.93 | 2022 | |
| La Jolla Pharmaceutical Company | $15.46 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dimaio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.